Trademark Attorney / Law Firm

Andrew R. Schneidman – Trademark Portfolio

Andrew R. Schneidman specializes in Class 35 (Advertising & Business) trademark filings before the United States Patent and Trademark Office (USPTO), with 4 of 5 total filings concentrated in this category. The practice also covers Class 44 (Medical Services) along with 2 other Nice Classification classes. Filing activity spans from 2024 to 2025. Currently, 5 trademarks are registered.

5 Total Trademarks
Loading...
By Date
By Name
Filter by Class:

Practice Areas by Trademark Class

Andrew R. Schneidman's trademark practice covers 2 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.

35
Advertising & Business (4 filings)

Advertising; business management; business administration; office functions

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademark applications has Andrew R. Schneidman filed?

Andrew R. Schneidman has filed 5 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 5 registered.

What trademark classes does Andrew R. Schneidman specialize in?

Andrew R. Schneidman has filed trademarks across 2 Nice Classification classes. The most common practice areas include Class 35 (Advertising & Business), Class 44 (Medical Services). Class 35 covers advertising; business management; business administration; office functions.

How long has Andrew R. Schneidman been filing trademarks?

Andrew R. Schneidman's trademark filing history with the USPTO spans from 2024 to 2025, covering 1 year of trademark practice. During this period, Andrew R. Schneidman has handled 5 trademark applications.

What is Andrew R. Schneidman's trademark registration success rate?

Andrew R. Schneidman has a 100% trademark registration rate, with 5 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.